TABLE OF CONTENTS
|  |  |  | Volume 30, Issue 29 (July 2011) |  | In this issue
Original Articles
Short Communications
Also new
   AOP
| |  |  |  | Advertisement |  |
Nature Publishing Group Language Editing
NPG Language Editing is a high-quality English language editing service for authors submitting papers for publication in scientific and medical journals. Our focus is on improving the clarity and sense of the written manuscript, so that your research results stand out.
Visit NPG Language Editing online to see how you can benefit from our expertise. |
|  | | Original Articles | Top |  | The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressorV M Renault, P U Thekkat, K L Hoang, J L White, C A Brady, D Kenzelmann Broz, O S Venturelli, T M Johnson, P R Oskoui, Z Xuan, E E Santo, M Q Zhang, H Vogel, L D Attardi and A Brunet Oncogene 2011 30: 3207-3221; advance online publication, March 21, 2011; 10.1038/onc.2011.35 Abstract | Full Text |  |  |  | PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugsB Weigelt, P H Warne and J Downward Oncogene 2011 30: 3222-3233; advance online publication, February 28, 2011; 10.1038/onc.2011.42 Abstract | Full Text |  |  |  | Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activationP Dhawan, R Ahmad, R Chaturvedi, J J Smith, R Midha, M K Mittal, M Krishnan, X Chen, S Eschrich, T J Yeatman, R C Harris, M K Washington, K T Wilson, R D Beauchamp and A B Singh Oncogene 2011 30: 3234-3247; advance online publication, March 7, 2011; 10.1038/onc.2011.43 Abstract | Full Text |  |  |  | Sds22/PP1 links epithelial integrity and tumor suppression via regulation of myosin II and JNK signalingY Jiang, K L Scott, S-J Kwak, R Chen and G Mardon Oncogene 2011 30: 3248-3260; advance online publication, March 14, 2011; 10.1038/onc.2011.46 Abstract | Full Text |  |  |  | Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout miceE Buache, N Etique, F Alpy, I Stoll, M Muckensturm, B Reina-San-Martin, M P Chenard, C Tomasetto and M C Rio Oncogene 2011 30: 3261-3273; advance online publication, February 28, 2011; 10.1038/onc.2011.41 Abstract | Full Text |  |  |  | The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cellsG Donati, S Bertoni, E Brighenti, M Vici, D Treré, S Volarevic, L Montanaro and M Derenzini Oncogene 2011 30: 3274-3288; advance online publication, March 14, 2011; 10.1038/onc.2011.48 Abstract | Full Text |  | Short Communications | Top |  | Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategyS Gramling, C Rogers, G Liu and D Reisman Oncogene 2011 30: 3289-3294; advance online publication, April 11, 2011; 10.1038/onc.2011.80 Abstract | Full Text |  |  |  | Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer riskG Liu, S Gramling, D Munoz, D Cheng, A K Azad, M Mirshams, Z Chen, W Xu, H Roberts, F A Shepherd, M S Tsao and D Reisman Oncogene 2011 30: 3295-3304; advance online publication, April 11, 2011; 10.1038/onc.2011.81 Abstract | Full Text |  |  |  |  |  | Advertisement |  | Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.
Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper. |
|  | |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | |
|
|
No comments:
Post a Comment